Adoptive Cellular Immunotherapy of CancerThis volume presents the most complicated and powerful cancer biotherapies developed. It provides an overview of human immune system function and the mechanisms by which adoptive cellular immunotherapies (ACI) harnesses the activity. The volume provides a vision on the developments in ACI. |
Other editions - View all
Common terms and phrases
A-PBL ACI therapy ACI trials activated killer activated killer cells Adoptive Cellular Immunotherapy adoptive immunotherapy antigen apheresis assay autologous tumor Biological Response Modifiers biotherapy bolus cancer biotherapy cancer patients Cancer Res carcinoma cellular therapy centrifugal clinical trials continuous infusion cytapheresis cytes cytokine cytolytic developed effector cells efficacy function glioma human blood monocytes human monocytes human tumors IFN-y IL-2 and LAK IL-2 plus LAK immune system Immunol Immunology infiltrating interferon interleukin-2 intraperitoneal laboratory LAK activity LAK cells large numbers leukapheresis leukocyte leukocyte subsets lympho lymphokine lymphokine-activated killer cells lysis lytic macrophages malignant melanoma metastatic monocytes mononuclear cells murine natural killer ovarian peripheral blood peritoneal Phase phenotype preclinical protocol purified receptor recombinant interleukin-2 regimen reinfusion Rosenberg serum serum-free solid tumors studies Table target cells TDAC TGF-ẞ therapeutic tients tion toxicity treatment tumor cells tumor necrosis factor tumor targets tumor-infiltrating tumoricidal units/ml vitro vivo Yannelli